Summary of Changes

4. In the case of a serious breach of Agency policy, agrees that the Agency may publicly disclose his or her name, the nature of the breach, the institution where he or she was employed at the time of the breach and the institution where he or she is currently employed.

• prospectively register their trial in a registry acceptable to the World Health Organization (WHO) or the International Council of Journal Editors (ICMJE). This includes providing the WHO Trial Registration Data Set;
• update the trial registry with any changes in the trial protocol, adverse events that occur during a trial, and decisions taken to end a trial early;
• disclose serious adverse events at the end of the trial in subsequent publications and to the registry;
• deposit aggregate data in an unbiased, publicly accessible database (e.g. the registry); and
• if conducting a CIHR-funded randomized control trial (RCT), submit a report in the Consolidated Standards of Reporting Trials (CONSORT) format within 12 months of the end of the trial.

1-G3 Authorized Official at the Research Institution (Primary Location of Research) (Training Award Programs only)

For training award applications, CIHR requires the signature of the institution under the Institution Paid signature block. In some cases, the applicant is not affiliated with a CIHR eligible Institution Paid. For example, the award is held outside of Canada or the institution is not a CIHR eligible Institution Paid. For CIHR eligible institutions, both signatures as Institution Paid and Research Institution are required.

In addition, CIHR requires the signature from the Research Institution. As a result, a new subsection in the CIHR Grants and Awards Guide outlining the meaning of signatures on applications forms for those officials at research institutions (primary locations of research) to clarify the roles and responsibilities of officials at research institutions (primary locations of research) in the management of federal awards has been created.

For the roles and responsibilities of research institutions (primary locations of research) in the management of federal awards, consult the meaning of signatures on applications forms for officials at research institutions (primary locations of research) subsection.

1. awardees may now apply to 2 training awards simultaneously in certain circumstances (e.g., applications to CIHR training award programs and tri-agency programs such as Vanier Canada Graduate Scholarships and Banting Postdoctoral Fellowships).
2. offers of award are now available through ResearchNet instead of being sent by courier.
3. an attempt to standardize with the other funding agencies in Canada.
4. ability to provide the most awards possible within a given fiscal year.

As a result of the timeframe review, successful recipients of salary and training awards must now notify CIHR that they are accepting their offer of award within fifteen (15) business days (as opposed to 40 business days) following the communication of competition results.

The shorter timeframe to accept an offer will allow CIHR to maximize research capacity by making additional offers of awards in a timelier manner, thus reducing the risk of lapsed funding.

Failure to notify CIHR within this new timeframe will result in the award being cancelled. CIHR has successfully piloted this approach recently with the Fellowships program.

When a training award recipient takes a maternity and/or parental leave, the research allowance is held in abeyance. Upon confirmation of return to the research training environment, the training award recipient may spend the remainder of the research allowance over the remaining (extended) duration of the award. Recipients of training awards may not request additional research allowances.

1. The Nominated Principal Applicant (NPA) on a grant may now add, promote or remove Principal Applicants and Co-Applicants on their existing grants, provided that:
   1. the individuals added, replaced or promoted meet the individual eligibility requirements as outlined in the original funding opportunity description; and
   2. the rationale for adding, replacing, promoting or removing individuals has been deemed justifiable by the authorized official at the Institution Paid. The signature of the authorized official at the Institution Paid on the Request to Replace, Add, Remove or Promote Individuals on Existing Grants confirms that the changes are justifiable. Note: CIHR will deny the request if the authorized official at the Institution Paid has not signed the Request to Replace, Add, Remove or Promote Individuals on Existing Grants.
2. The replacement of individuals on existing grants is no longer limited to a change in eligibility.

The Nominated Principal Applicant is encouraged to communicate and ensure agreement on changes of this nature to project participants. Confirmation from existing Principal Applicants and Co-Applicants is not required for CIHR to process a request to add, replace, promote or remove individuals on or from grants.

For CIHR's policy on replacement, addition, removal or promotion of principal applicants and co applicants (existing grants), including examples of justifiable changes, consult the Replacement, Addition, Removal or Promotion of Principal Applicants and Co Applicants (Existing Grants) subsection.